Aminocaproic acid
A potent antifibrinolytic agent used to manage excessive bleeding in surgical and clinical conditions. Optimized for high-purity pharmaceutical grade applications.
Description
Comprehensive Product Overview
In the competitive landscape of hematological care, ingredient quality defines the clinical outcome. Zyntex Aminocaproic acid is selected for its ability to enhance clot stability and therapeutic efficacy without compromising patient safety. Therefore, we utilize an advanced chemical synthesis process to create low-molecular-weight crystalline peptides. Consequently, this versatile ingredient delivers reliable performance across a wide range of surgical conditions, ensuring rapid inhibition of fibrinolysis in human medical treatments.
Zyntex supplies Aminocaproic acid in a highly soluble white powder form, optimized for easy integration into complex parenteral and oral liquid synthesis processes. Our stringent quality control measures ensure high purity and minimal organic impurity content. Furthermore, this product features a consistent chemical profile. Since it acts by competitively inhibiting plasminogen activators, you can incorporate it into various products like injectable solutions, oral tablets, or specialized surgical rinses without affecting the intended therapeutic experience.
From specialized laboratory research to large-scale industrial manufacturing, this versatile ingredient is a staple for modern formulation. Its consistent chemical profile ensures it does not interfere with the desired characteristics of the end product. As a result, Zyntex provides a dependable foundation for innovation in the emergency medicine and surgical hemostasis markets. Finally, our commitment to safety and international standards helps your brand achieve regulatory compliance and global market trust effortlessly.
Key Industrial Applications
This professional-grade hemostatic agent is widely utilized in the following sectors:
💉 Surgical Hemostasis
It acts as an active component to control bleeding during complex cardiac or orthopedic surgeries.
💊 Oral Formulations
This is an essential ingredient for tablets and syrups used to manage chronic bleeding disorders.
🏥 Critical Care
Used as a primary treatment in hospitals for acute hyperfibrinolysis and traumatic hemorrhage cases.
🧪 Lab Research
A high-grade reference standard for fibrinolysis studies and protein degradation laboratory experiments.
Technical Specifications
| Parameter | Specification Standard |
|---|---|
| Product Name | Aminocaproic acid |
| Grade | Pharmaceutical Grade (USP/EP) |
| Assay | 98.5% – 101.5% |
| Category | Antifibrinolytics & Hemostatics |
| CAS Number | 60-32-2 |
🔬 Scientific Data: For detailed handling, solubility, and safety data, consult: PubChem Entry: Aminocaproic acid (External Link)
